UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development

Cancer prevention research (Philadelphia, Pa.), 2018-07, Vol.11 (7), p.371-382

2018

Volltextzugriff (PDF)

Sp transcription factor family and its role in cancer

European journal of cancer (1990), 2005-11, Vol.41 (16), p.2438-2448

2005

Volltextzugriff (PDF)

The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies

Biomedicines, 2021-04, Vol.9 (4), p.389

2021

Volltextzugriff (PDF)

Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer

The Journal of biological chemistry, 2014-10, Vol.289 (40), p.27692-27701

2014

Volltextzugriff (PDF)

The Uncharted Territories of Esophageal Cancer with Cardiac and Skeletal Muscle Metastasis: A Case Report and Literature Review

Medicina (Kaunas, Lithuania), 2024-07, Vol.60 (7), p.1146

2024

Volltextzugriff (PDF)

Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature

Journal for immunotherapy of cancer, 2019-04, Vol.7 (1), p.106-106, Article 106

2019

Volltextzugriff (PDF)

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

Journal for immunotherapy of cancer, 2019-01, Vol.7 (1), p.2-13, Article 2

2019

Volltextzugriff (PDF)

Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report

Current oncology (Toronto), 2022-06, Vol.29 (6), p.4267-4273

2022

Volltextzugriff (PDF)

Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review

Frontiers in pharmacology, 2021-12, Vol.12

2021

Volltextzugriff (PDF)

Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments

Frontiers in oncology, 2024-07, Vol.14, p.1386699

2024

Volltextzugriff (PDF)

Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma

PloS one, 2015-06, Vol.10 (6), p.e0128308-e0128308

2015

Volltextzugriff (PDF)

Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis

Oncoimmunology, 2021-01, Vol.10 (1), p.1927313-1927313

2021

Volltextzugriff (PDF)

Cyclooxygenase-2 Inhibitors Decrease Vascular Endothelial Growth Factor Expression in Colon Cancer Cells by Enhanced Degradation of Sp1 and Sp4 Proteins

Molecular pharmacology, 2005-08, Vol.68 (2), p.317-329

2005

Volltextzugriff (PDF)

Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening

Current oncology (Toronto), 2022-11, Vol.29 (11), p.8693-8719

2022

Volltextzugriff (PDF)

Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis

Oncoimmunology, 2021-01, Vol.10 (1), p.1877415-1877415

2021

Volltextzugriff (PDF)

3,3′-Diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5

Carcinogenesis (New York), 2006-04, Vol.27 (4), p.717-728

2006

Volltextzugriff (PDF)

Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series

Current oncology (Toronto), 2022-05, Vol.29 (5), p.3585-3594

2022

Volltextzugriff (PDF)

Tolfenamic Acid and Pancreatic Cancer Growth, Angiogenesis, and Sp Protein Degradation

JNCI : Journal of the National Cancer Institute, 2006-06, Vol.98 (12), p.855-868

2006

Volltextzugriff (PDF)

Methyl 2-Cyano-3,12-dioxooleana-1,9-dien-28-oate Decreases Specificity Protein Transcription Factors and Inhibits Pancreatic Tumor Growth: Role of MicroRNA-27a

Molecular pharmacology, 2010-08, Vol.78 (2), p.226-236

2010

Volltextzugriff (PDF)

Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer

Frontiers in oncology, 2022-12, Vol.12, p.992455

2022

Volltextzugriff (PDF)

Targeting SP1 Transcription Factor in Prostate Cancer Therapy

Medicinal chemistry (Shp-sariqah, United Arab Emirates), 2011-09, Vol.7 (5), p.518-525

2011

Volltextzugriff (PDF)

725 Immunomodulation by targeting PDL-1 in colon cancer using nuclear receptor 4A1 (NR4A1) antagonists

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A754-A755

2021

Volltextzugriff (PDF)

The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma

Pharmaceuticals (Basel, Switzerland), 2024-07, Vol.17 (7), p.910

2024

Volltextzugriff (PDF)

Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer

Cancer chemotherapy and pharmacology, 2020-03, Vol.85 (3), p.621-626

2020

Volltextzugriff (PDF)

Intrahepatic cholangiocarcinoma: The role of liver transplantation, adjunctive treatments, and prognostic biomarkers

Frontiers in oncology, 2022-11, Vol.12, p.996710-996710

2022

Volltextzugriff (PDF)

1 – 25 von 217

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancers

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(193)

Publikationsform

Sprache

Englisch
(217)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development

Sp transcription factor family and its role in cancer

The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies

Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer

The Uncharted Territories of Esophageal Cancer with Cardiac and Skeletal Muscle Metastasis: A Case Report and Literature Review

Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report

Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review

Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments

Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma

Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis

Cyclooxygenase-2 Inhibitors Decrease Vascular Endothelial Growth Factor Expression in Colon Cancer Cells by Enhanced Degradation of Sp1 and Sp4 Proteins

Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening

Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis

3,3′-Diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5

Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series

Tolfenamic Acid and Pancreatic Cancer Growth, Angiogenesis, and Sp Protein Degradation

Methyl 2-Cyano-3,12-dioxooleana-1,9-dien-28-oate Decreases Specificity Protein Transcription Factors and Inhibits Pancreatic Tumor Growth: Role of MicroRNA-27a

Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer

Targeting SP1 Transcription Factor in Prostate Cancer Therapy

725 Immunomodulation by targeting PDL-1 in colon cancer using nuclear receptor 4A1 (NR4A1) antagonists

The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma

Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer

Intrahepatic cholangiocarcinoma: The role of liver transplantation, adjunctive treatments, and prognostic biomarkers

Aktive Filter

Suchergebnisse filtern